Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases

HPB

Volumn 15, Issue 8, 2013, Pages 646-652

  Sturesson, Christian ^a   Nilsson, Jan ^a   Eriksson, Sam ^a   Spelt, Lidewij ^a   Andersson, Roland ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; COHORT ANALYSIS; COLORECTAL LIVER METASTASIS; CONFERENCE PAPER; FEMALE; HUMAN; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY;

EID: 84880157011     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12040     Document Type: Conference Paper

References (48)

1. Jemal A, Siegel R, Xu J, Ward E,. (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300. Epub 2010/07/09.
2. Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G,. (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93: 465-474. Epub 2006/03/09.
3. Steele G, Jr, Ravikumar TS,. (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210: 127-138. Epub 1989/08/01.
4. Tan MC, Castaldo ET, Gao F, Chari RS, Linehan DC, Wright JK, et al. (2008) A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables. J Am Coll Surg 206: 857-868. discussion 68-9. Epub 2008/05/13.
5. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG,. (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247: 125-135. Epub 2007/12/25.
6. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: 818-825. discussion 25-7. Epub 2004/05/29.
7. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM,. (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240: 438-447. discussion 47-50. Epub 2004/08/21.
8. Pawlik TM, Schulick RD, Choti MA,. (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13: 51-64. Epub 2008/02/05.
9. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, et al. (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7: 325-330. Epub 2003/03/26.
10. Ferrero A, Vigano L, Polastri R, Muratore A, Eminefendic H, Regge D, et al. (2007) Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 31: 1643-1651. Epub 2007/06/07.
11. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127: 512-519. Epub 2000/05/20.
12. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231: 480-486. Epub 2000/04/05.
13. Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, et al. (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232: 665-672. Epub 2000/11/07.
14. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H,. (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232: 777-785. Epub 2000/11/23.
15. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8: 347-353. Epub 2001/05/16.
16. Ito K, Govindarajan A, Ito H, Fong Y,. (2010) Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J 16: 103-110. Epub 2010/04/21.
17. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224: 509-520. discussion 20-2. Epub 1996/10/01.
18. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, et al. (2004) Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15: 933-939. Epub 2004/05/21.
19. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016. Epub 2008/03/25.
20. Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H,. (2003) Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90: 963-969. Epub 2003/08/09.
21. Peppercorn PD, Reznek RH, Wilson P, Slevin ML, Gupta RK,. (1998) Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 77: 2008-2011. Epub 1998/07/17.
22. Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP, et al. (2007) Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 94: 1395-1402. Epub 2007/07/04.
23. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072. Epub 2006/05/02.
24. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466. Epub 2004/03/05.
25. Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, et al. (2011) Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol 18: 421-430. Epub 2010/09/17.
26. Beal IK, Anthony S, Papadopoulou A, Hutchins R, Fusai G, Begent R, et al. (2006) Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol 79: 473-478. Epub 2006/05/23.
27. Sturesson C, Keussen I, Tranberg KG,. (2010) Prolonged chemotherapy impairs liver regeneration after portal vein occlusion-an audit of 26 patients. Eur J Surg Oncol 36: 358-364. Epub 2010/01/27.
28. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, et al. (2000) Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 69: 1375-1379. Epub 2000/05/08.
29. Pomfret EA, Pomposelli JJ, Gordon FD, Erbay N, Lyn Price L, Lewis WD, et al. (2003) Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 76: 5-10. Epub 2003/07/17.
30. Nadalin S, Testa G, Malago M, Beste M, Frilling A, Schroeder T, et al. (2004) Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl 10: 1024-1029. Epub 2004/09/25.
31. Nagino M, Ando M, Kamiya J, Uesaka K, Sano T, Nimura Y,. (2001) Liver regeneration after major hepatectomy for biliary cancer. Br J Surg 88: 1084-1091. Epub 2001/08/08.
32. Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al. (2002) Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8: 233-240. Epub 2002/03/23.
33. Dindo D, Demartines N, Clavien PA,. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213. Epub 2004/07/27.
34. Tanaka K, Kumamoto T, Matsuyama R, Takeda K, Nagano Y, Endo I,. (2010) Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg 14: 359-368. Epub 2009/11/06.
35. Tani M, Tomiya T, Yamada S, Hayashi S, Yahata K, Tamura Y, et al. (1994) Regulating factors of liver regeneration after hepatectomy. Cancer Chemother Pharmacol 33 (Supp l): S29-S32. Epub 1994/01/01.
36. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN,. (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94: 1386-1394. Epub 2007/06/23.
37. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, et al. (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247: 451-455. Epub 2008/04/01.
38. Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J,. (2009) Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol 16: 1553-1559. Epub 2009/04/14.
39. de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, et al. (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17: 2081-2089. Epub 2010/03/20.
40. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, et al. (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247: 118-124. Epub 2007/12/25.
41. Brouquet A, Benoist S, Julie C, Penna C, Beauchet A, Rougier P, et al. (2009) Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 145: 362-371. Epub 2009/03/24.
42. Welsh FK, Tilney HS, Tekkis PP, John TG, Rees M,. (2007) Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 96: 1037-1042. Epub 2007/03/14.
43. Hockings PD, Changani KK, Saeed N, Reid DG, Birmingham J, O'Brien P, et al. (2003) Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. Diabetes Obes Metab 5: 234-243. Epub 2003/06/11.
44. van den Esschert JW, de Graaf W, van Lienden KP, Busch OR, Heger M, van, Delden OM, et al. (2009) Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization: recovery after PVE and liver resection. J Gastrointest Surg 13: 1464-1469. Epub 2009/05/29.
45. Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, et al. (1993) Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 18: 79-85. Epub 1993/07/01.
46. Shimizu Y, Aoki T, Kusano T, Matsuda K, Enami Y, Yasuda D, et al. (2010) Natural course of the remnant hepatic functional reserve as estimated by technetium-99m-galactosyl human serum albumin scintigraphy after a hepatectomy. J Gastroenterol 45: 308-316. Epub 2009/11/07.
47. Aoki T, Imamura H, Matsuyama Y, Kishi Y, Kobayashi T, Sugawara Y, et al. (2011) Convergence process of volumetric liver regeneration after living-donor hepatectomy. J Gastrointest Surg 15: 1594-1601. Epub 2011/06/29.
48. de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van, Gulik TM,. (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98: 825-834. Epub 2011/04/13.